Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis

NCT00737100 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

510

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Placebo Respimat
DRUG: Tiotropium bromide 5 mcg
DRUG: tiotropium bromide-low dose-2.5mcg

Sponsor

Boehringer Ingelheim